| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | US20040199935 Cytoplasmic transfer to de-differentiate recipient cells |
| 10/07/2004 | US20040198970 Maxp1 |
| 10/07/2004 | US20040198969 Compositions and methods for the diagnosis and treatment of tumor |
| 10/07/2004 | US20040198689 Ribozyme sequences related to hiv resistance |
| 10/07/2004 | US20040198688 for treatment of atopic conditions (dermatitis, allergies); point mutations |
| 10/07/2004 | US20040198687 Endosomolytic polymers |
| 10/07/2004 | US20040198685 For prophylaxis and therapy of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen |
| 10/07/2004 | US20040198683 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 10/07/2004 | US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) |
| 10/07/2004 | US20040198678 Intravascular delivery of non-viral nucleic acid |
| 10/07/2004 | US20040198659 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 10/07/2004 | US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198649 a VR4 peptide, a VR4 polypeptide modulator, a VR4 polynucleotide, or an antisense agent as analgesics or antiarthritic agents for bone and cartilage disorders; rheumatoid and osteoarthritis, osteoperosis; biodrugs |
| 10/07/2004 | US20040197913 Enhancing viral insertion into mammalian genomes via inhibition of replication/repair proteins; gene therapy and heterologus gene expression |
| 10/07/2004 | US20040197910 Gene regulation in transgenic animals using a transposon-based vector |
| 10/07/2004 | US20040197902 Transgenic mammalian endothelial progenitor cells for use in the treatment of vision defects; gene therapy and neovascularization |
| 10/07/2004 | US20040197883 Apparatus and method for electroporation of biological samples |
| 10/07/2004 | US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197860 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 10/07/2004 | US20040197827 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 10/07/2004 | US20040197798 Using alteration in phosphorylation to detect, diagnose, prevent and prognose cell proliferative disorders |
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197766 Using transgenic animal models to identify modulator for treatment of obesity, cachexia, diabetes, insulin resistance and eating disorders |
| 10/07/2004 | US20040197393 sandwich liposome comprises one or more biologically active agents internalized between two bilomellar liposomes; (1,2-bis(oleoyloxy)-3-(trimethylammonio)-propane) and cholesterol and a nucleic acid |
| 10/07/2004 | US20040197390 Mixture of expression vector for antihemophilic factor and lipid; delivering of DNA expression vehicle encoding Factor VIII to a cell |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197329 Remedies or preventives for rheumatoid arthritis |
| 10/07/2004 | US20040197318 Chelating systems for use in the delivery of compounds to cells |
| 10/07/2004 | US20040197317 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 10/07/2004 | US20040197316 Novel method for the treatment of systemic lupus erythematosus |
| 10/07/2004 | US20040197315 Parkinson's diisease; central nervous system disorders ; Alzheimer's disease; neurodegenerative disorders |
| 10/07/2004 | US20040197314 gene expression of polypeptide in membrane vesicle ; forming antibodies; controlling immunology response |
| 10/07/2004 | US20040197313 Promoter construct for gene expression in neuronal cells |
| 10/07/2004 | US20040197308 Dna which controls gene expression; insertion of gene into tumor cells |
| 10/07/2004 | CA2519517A1 Compositions and methods of using hexokinase v |
| 10/07/2004 | CA2519114A1 Methods and compositions for treating and preventing inflammatory conditions |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464704A2 Mouse adhesion molecule occludin |
| 10/06/2004 | EP1464703A2 Canine adhesion molecule occludin |
| 10/06/2004 | EP1464651A1 Dystrophin-related protein (Drop1), a marker for carcinomas |
| 10/06/2004 | EP1463836A2 Vector mediated organelle transfection |
| 10/06/2004 | EP1463834A2 Identification of an amplified gene and target for drug intervention |
| 10/06/2004 | EP1463827A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/06/2004 | EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 10/06/2004 | EP1463803A2 Hematopoietic cells from human embryonic stem cells |
| 10/06/2004 | EP1463798A2 Islet cells from human embryonic stem cells |
| 10/06/2004 | EP1463797A2 Methods of kidney transplantation utilizing developing nephric tissue |
| 10/06/2004 | EP1463758A2 Mammal prolactin variants |
| 10/06/2004 | EP1463757A2 Antisense compounds directed against human csf-1 |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463746A2 Antisense modulation of mucin 1, transmembrane expression |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463530A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles |
| 10/06/2004 | EP1463520A2 Immunisation against chlamydia trachomatis |
| 10/06/2004 | EP1463518A2 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| 10/06/2004 | EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap |
| 10/06/2004 | EP1463409A2 Gene delivery system and methods of use |
| 10/06/2004 | EP1390518B1 Buffer solution for electroporation and a method comprising the use of the same |
| 10/06/2004 | EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 10/06/2004 | EP1272652B1 Herpes viruses for immune modulation |
| 10/06/2004 | EP1239834B1 Mixed structures resulting from the incorporation of a biological macromolecule, especially dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 10/06/2004 | EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 10/06/2004 | EP1012295B1 Alphavirus rna replicon systems |
| 10/06/2004 | EP0972017B1 Efficient nuclear transfer using fetal fibroblasts |
| 10/06/2004 | EP0862643B1 Accessory functions for use in recombinant aav virion production |
| 10/06/2004 | EP0844871B1 A process for preparing microparticles through phase inversion phenomena |
| 10/06/2004 | EP0833934B1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/06/2004 | CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/06/2004 | CN1535312A PUFA polyketide synthase systems and uses thereof |
| 10/06/2004 | CN1535163A Delivery system for nucleic acids |
| 10/06/2004 | CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 10/06/2004 | CN1535156A Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/06/2004 | CN1169966C Isolated, tyrosinase derived peptides and uses thereof |
| 10/06/2004 | CN1169949C Preparation of recombination adenovirus construction body with deletion E1A code sequence and its use |
| 10/06/2004 | CN1169824C Polytype gene of MXA protein and application thereof |
| 10/05/2004 | US6801805 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 10/05/2004 | US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 10/05/2004 | US6800731 For detecting myeloid cells expressing oncogene and therapeutic methods for treating cell-proliferative diseases |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 10/05/2004 | US6800479 Tumor therapy |
| 10/05/2004 | US6800475 Used as a vector for gene therapy or as a recombinant virus vaccine; pathogenicity studies; screening for spumavirus infection |
| 10/05/2004 | US6800461 The b-domain of the wild-type factor viii cdna has been deleted and a truncated factor ix intron 1 has been inserted in one or more locations of the factor viii cdna; vector for human gene therapy |
| 10/05/2004 | US6800458 Manganese superoxide dismutase regulatory elements and uses thereof |
| 10/05/2004 | US6800447 Methods for identifying compounds which bind the active CCR5 chemokine receptor |
| 10/05/2004 | US6800440 Detecting genetic disorder; obtain sample, detect bone morphogenic protein mutation, the presence of mutation indicates genetic disorder |
| 10/05/2004 | US6800436 Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in LKB1 gene |
| 10/05/2004 | US6800281 Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases |
| 09/30/2004 | WO2004083446A2 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 09/30/2004 | WO2004083435A1 Nab proteins and their use in diagnostic and therapeutic applications in heart disease |
| 09/30/2004 | WO2004083434A1 A combined adeno-associated virus and adenovirus cocktail gene delivery system for high effiency gene expression without eliciting immune response in immuno-competent subjects |
| 09/30/2004 | WO2004083432A1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 09/30/2004 | WO2004083398A2 Therapeutic uses of hmgn1 and hmgn2 |
| 09/30/2004 | WO2004083383A2 Globin variant gene methods and compositions |
| 09/30/2004 | WO2004083380A2 Methods and compositions for modulating glycogen synthesis and breakdown |